Gilead Sciences, Inc. Says U.S. Upholds One Viread Patent

LOS ANGELES, May 20 (Reuters) - Gilead Sciences Inc said on Tuesday that U.S. patent officials have upheld one of the four challenged patents covering its AIDS medicine Viread.
MORE ON THIS TOPIC